NYSEAMERICAN:SENSSenseonics Stock Price, Forecast & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Senseonics.

Senseonics Holdings Inc (NYSEAMERICAN:SENS) issued its earnings results on Thursday, March, 12th. The company reported ($0.18) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.16) by $0.02. The business earned $9 million during the quarter, compared to analyst estimates of $7.93 million. View Senseonics' earnings history.

Senseonics updated its FY 2020 After-Hours earnings guidance on Thursday, March, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $15-20 million, compared to the consensus revenue estimate of $36.29 million.

8 Wall Street analysts have issued twelve-month price objectives for Senseonics' shares. Their forecasts range from $0.25 to $2.00. On average, they anticipate Senseonics' share price to reach $1.23 in the next twelve months. This suggests a possible upside of 156.9% from the stock's current price. View analysts' price targets for Senseonics.

News headlines about SENS stock have been trending somewhat positive on Friday, InfoTrie reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Senseonics earned a news sentiment score of 0.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an effect on the company's share price in the near term. View the latest news aboutSenseonics.

Some companies that are related to Senseonics include Volpara Health Tech (VHT), Profound Medical (PRN), Renalytix Ai (RENX), Akumin (AKU), Exagen (XGN), Yourgene Health (YGEN), Palatin Technologies (PTN), MaxCyte (MXCT), Oncosil Medical (OSL), Lexagene (LXG), Oncimmune (ONC), Genedrive (GDR), SQI Diagnostics (SQD), BARD1 Life Sciences (BD1) and Sernova (SVA). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include Advanced Micro Devices (AMD), Agile Therapeutics (AGRX), Amarin (AMRN), Crispr Therapeutics (CRSP), Sorrento Therapeutics (SRNE), Tandem Diabetes Care (TNDM), VirnetX (VHC), Micron Technology (MU), Nabriva Therapeutics (NBRV) and Protalix Biotherapeutics (PLX).

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics' stock is owned by many different institutional and retail investors. Top institutional shareholders include NEA Management Company LLC (13.71%), BlackRock Inc. (4.38%), State Street Corp (0.91%), Geode Capital Management LLC (0.82%), Raymond James Financial Services Advisors Inc. (0.28%) and Nuveen Asset Management LLC (0.24%). Company insiders that own Senseonics stock include Douglas A Roeder, Mukul Jain and Timothy T Goodnow. View institutional ownership trends for Senseonics.

SENS stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Morgan Stanley, UBS Group AG, BlackRock Inc., Spark Investment Management LLC, Raymond James Financial Services Advisors Inc., and Rhumbline Advisers. View insider buying and selling activity for Senseonics.

SENS stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Beacon Pointe Advisors LLC, Geode Capital Management LLC, Squarepoint Ops LLC, Alliancebernstein L.P., Advisor Group Holdings Inc., Wells Fargo & Company MN, and Palisades Hudson Asset Management L.P.. View insider buying and selling activity for Senseonics.

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $0.48.

Senseonics has a market capitalization of $107.11 million. Senseonics employs 191 workers across the globe.

The official website for Senseonics is www.senseonics.com.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.